Hu, Jian Ming <br/><br/>
CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.  [electronic resource] 

 -  Oncotarget  Mar 2017 
 - 21526-21538 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.15630  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, Myelomonocytic--immunology<br/>Asian People<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Squamous Cell--immunology<br/>Esophageal Neoplasms--immunology<br/>Esophageal Squamous Cell Carcinoma<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Macrophage Activation--immunology<br/>Macrophages--immunology<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Middle Aged<br/>Neovascularization, Pathologic--pathology<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Cell Surface--immunology<br/>Tumor Microenvironment--immunology<br/>CD163 Antigen